SLNO - SOLENO THERAPEUTICS INC

39.68
1.110   2.797%

Share volume: 1,755,090
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$38.57
1.11
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 0%
Dept financing 19%
Liquidity 56%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.59%
1 Month
-2.94%
3 Months
-22.47%
6 Months
-45.12%
1 Year
-11.39%
2 Year
-11.71%
Key data
Stock price
$39.68
P/E Ratio 
121.45
DAY RANGE
$37.50 - $39.74
EPS 
$0.40
52 WEEK RANGE
$32.63 - $90.32
52 WEEK CHANGE
-$9.16
MARKET CAP 
2.487 B
YIELD 
N/A
SHARES OUTSTANDING 
51.624 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
1.11
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,909,505
AVERAGE 30 VOLUME 
$1,409,035
Company detail
CEO: Anish Bhatnagar
Region: US
Website: soleno.life
Employees: 30
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.

Recent news